Drug intelligence / Profile preview

mbdb

Development stage
Unknown
Lead developer
David E. Nichols
Modality
Small Molecules
Administration
Oral
01

Overview

MBDB (3,4-methylenedioxy-alpha-ethyl-N-methylphenethylamine) is a lesser-known hallucinogenic phenethylamine and an analog of MDMA. It is also known as "EDEN" or "Methyl-J." MBDB was first synthesized by David E. Nichols and later tested by Alexander Shulgin. Its effects are similar to but milder than those of MDMA; it lowers social barriers and inhibitions and produces a sense of empathy and mild euphoria. However, it lacks the pronounced stimulant or psychedelic effects seen with MDMA. The typical dosage is 180–210 mg orally; duration of action is about 4–6 hours with after-effects lasting up to 1–3 hours[2][8][9].

Other names
3,4-methylenedioxy-alpha-ethyl-N-methylphenethylamine2-methylamino-1-(3,4-methylenedioxyphenyl)butane
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on mbdb.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mbdb.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call